Insulet PODD
NASDAQ PODD
$134.60 -3.32 (-2.41%)
As of: Sep 10, 2026 · 2:10 PM EDT

Insulet (PODD) Operating Income (2010 - 2026)

Insulet's (PODD) quarterly Operating Income came in at $129.7 million in Q2 2026, up 7.1% on a YoY basis from $121.1 million in Q2 2025, and up 6.22% quarter-over-quarter from $122.1 million in Q1 2026.

Analysis

Insulet (PODD) Operating Income (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Operating Income for 17 consecutive years, with $129.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Income rose 7.1% year-over-year to $129.7 million; the trailing twelve-month figure through Jun 2026 stood at $515.8 million (up 26.64% YoY), and the FY2025 full-year result was $473.8 million, up 53.38% from the prior year.
  • Operating Income climbed to $129.7 million in Q2 2026 per PODD's latest filing, from $122.1 million in the prior quarter.
  • Across five years, Operating Income topped out at $146.3 million in Q4 2025 and bottomed at -$26.7 million in Q2 2022.
  • Historically, Operating Income has averaged $71.8 million across 5 years, with a median of $72.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Operating Income tumbled 201.52% in 2022, then surged 1789.66% in 2023.
  • Over 5 years, Operating Income stood at $23.5 million in 2022, then surged by 353.19% to $106.5 million in 2023, then advanced by 2.63% to $109.3 million in 2024, then jumped by 33.85% to $146.3 million in 2025, then retreated by 11.35% to $129.7 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered $129.7 million, $122.1 million, and $146.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn 1.69 Bn
2 Intuitive Surgical 127.32 Bn 122.10 Bn 1.96 Bn 971.90 Mn
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn 1.76 Bn
4 Stryker 103.97 Bn 100.50 Bn 4.50 Bn 1.66 Bn
5 Boston Scientific 63.66 Bn 63.12 Bn 3.85 Bn 1.18 Bn
6 Edwards Lifesciences 49.73 Bn 45.48 Bn 1.35 Bn 513.20 Mn
7 Alcon 33.00 Bn 31.54 Bn 1.68 Bn 11.00 Mn
8 Dexcom 32.04 Bn 30.09 Bn 830.00 Mn 318.30 Mn
9 Steris 20.70 Bn 20.22 Bn 684.20 Mn 285.80 Mn
10 Insulet 9.33 Bn 8.80 Bn 562.60 Mn 129.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 129.70 Mn
Mar 31, 2026 122.10 Mn
Dec 31, 2025 146.30 Mn
Sep 30, 2025 117.70 Mn
Jun 30, 2025 121.10 Mn
Mar 31, 2025 88.80 Mn
Dec 31, 2024 109.30 Mn
Sep 30, 2024 88.10 Mn
Jun 30, 2024 54.50 Mn
Mar 31, 2024 56.90 Mn
Dec 31, 2023 106.50 Mn
Sep 30, 2023 54.80 Mn
Jun 30, 2023 31.10 Mn
Mar 31, 2023 27.70 Mn
Dec 31, 2022 23.50 Mn
Sep 30, 2022 2.90 Mn
Jun 30, 2022 -26.70 Mn
Mar 31, 2022 37.90 Mn
Dec 31, 2021 49.70 Mn
Sep 30, 2021 33.70 Mn